Literature DB >> 8896069

History and development of Behçet's disease.

N Dilsen1.   

Abstract

I have tried to outline the history and development of Behçet's disease, which was first described in 1937 by Hulûsi Behçet, a Turkish Professor of Dermatology. The clinical picture is a triple symptom complex consisting of relapsing aphthous ulcers in the mouth and over the genitalia, and hypopion iritis. I have divided the developmental history of Behçet's disease into three periods: pre-Behçet, Behçet, and post-Behçet. Although similar clinical manifestations were mentioned in Hippocratic writings, clear examples of the symptomatic triad were not reported until the first quarter of this century. Since 1937, Behçet's disease has been a focus of active research. Exciting results concerning the genetics, immunology, molecular biology, diagnosis, and treatment of Behçet's disease have been obtained. It is hoped that the near future will bring additional discoveries to help solving difficulties in Behçet's disease.

Entities:  

Mesh:

Year:  1996        PMID: 8896069

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  7 in total

1.  Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach.

Authors:  Kenji Kobayashi; Fumiaki Ueno; Seiji Bito; Yasushi Iwao; Tsuneo Fukushima; Nobuo Hiwatashi; Masahiro Igarashi; Bun-Ei Iizuka; Takahide Matsuda; Toshiyuki Matsui; Takayuki Matsumoto; Akira Sugita; Mitsuhiro Takeno; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

2.  HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.

Authors:  Ayfer Atalay; Sanem Yildiz-Demirtepe; Sinan Tatlipinar; Berna Sanli-Erdoğan; Veli Cobankara; Cem Yildirim; Hüseyin Bağci; Erol Omer Atalay
Journal:  Mol Biol Rep       Date:  2007-06-27       Impact factor: 2.316

3.  Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experience.

Authors:  Arghya Chattopadhyay; Siddharth Jain; G S R S N K Naidu; Varun Dhir; Bharath Chhabria; Nupoor Acharya; Valliappan Muthu; Manphool Singhal; Ajay Savlania; Rajesh Vijayvergiya; Sanjay Jain; Aman Sharma
Journal:  Rheumatol Int       Date:  2021-10-18       Impact factor: 2.631

4.  Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet's syndrome.

Authors:  Yusuf Turkoz; Cem Evereklioglu; Abdullah Ozkiriş; Selçuk Mistik; Murat Borlu; Ibrahim H Ozerol; Fuat Duygulu; Ozgür Ilhan
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

5.  Laryngeal ulceration in Behçet's disease: the role of centres of excellence in the UK.

Authors:  Randa Ghazal Asswad; Anna Harrison; Paul S Hans; Casandra Buzatu
Journal:  J Surg Case Rep       Date:  2019-02-08

6.  Managing Behçet's disease: An update on current and emerging treatment options.

Authors:  P La van Daele; J H Kappen; P M van Hagen; J Am van Laar
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

Review 7.  Outcome predictors for intestinal Behçet's disease.

Authors:  Jae Jun Park; Won Ho Kim; Jae Hee Cheon
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.